Key facts
- Physiologas Technologies’s last known valuation is $7.1M (Jan 2026).
- It has raised $3.0M; the latest was Later Stage VC ($1.7M) in Jan 2026.
- Notable investors include Berkeley SkyDeck, Kyoto University Innovation Capital, Beyond Japan, Biojent, Brave Gate — 24 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Physiologas Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Physiologas Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Physiologas Technologies
Developer of a hemodialysis device designed for dialysis and home treatment. The company's portable equipment is used for dialysis care and acute myocardial infarction treatment using alternative energy resources, enabling patients to maintain their daily routines without the inconvenience of multiple hospital visits.
- Sector
- Healthcare
- HQ
- Sagamihara, Japan
- Founded
- 2020
- Employees
- 10
- Website
- physiologas.co.jp/
- Ownership
- Privately Held (backing)
Physiologas Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Physiologas Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Physiologas Technologies in its N-PORT filings yet. We sweep new filings monthly.